Systems biology towards novel chronic kidney disease diagnosis and treatment
Category
FP7 Project with U.S. partner
Short name and number
SysKID (241544)
Area
Health
Description
Chronic kidney disease (CKD) affects up to 10% of the population. Besides eventual progression towards end stage renal disease CKD impacts the patient s quality of life by causing serious comorbidities including cardiovascular complications and bone metabolism disorders. On the everyday clinical level early stage diagnosis and tailored treatment of CKD are still inadequate.
Participating Countries
Austria, Belgium, Denmark, Germany, Hungary, Italy, Poland, Spain, The Netherlands, United States, Israel and Switzerland.
Name of US Partner
CELERA CORPORATION
Contact
EMERGENTEC BIODEVELOPMENT GMBH (NL)